meh.Agreed. It will be interesting to see how the stock price reacts.
Can the company realistically afford to do this right now?ex-ghost said:HERE WE GO! Time to make some change at the top.
I would image it’s all about who would be tapped to replace NP. If it’s someone the market trusts the yes, if not probably not.Can the company realistically afford to do this right now?
They have to. It looks like no one in the industry will work with NP. Even if they hit a primary on a phase 3 trial, that doesn't mean the FDA has to grant an EUA. They need to get a grown-up in there.Can the company realistically afford to do this right now?
Much better. Really hoping we see around $1.60 on the stock price in the next month.
I think it will be happening. But we probably have a few months until it does.Crap. Bought more at $2.00. First buy since February. Really believing that management change will be happening.
Sounds like maybe by September, maybe.I think it will be happening. But we probably have a few months until it does.
plus 48 hrsand two weeksTwo months?
Leronlimab would love to be ivermectin.ivermectin says hello
It's not even THAT good. It's a press release to announce they haven't yet, but are going to, sometime over the next few days, submit a request to Brazil to authorize CYDY to conduct two trials.My god, what a terrible press release. An announcement to announce that they plan to submit a study in the next few days. WTF? Nader is trying to hold onto that big chair as long as he can.
https://www.cytodyn.com/newsroom/press-releases/detail/535/biomm-s-a-announces-plans-to-submit-authorization-to
I’d like to take credit for this but it’s low hanging fruit honestly…..My god, what a terrible press release. An announcement to announce that they plan to submit a study in the next few days. WTF? Nader is trying to hold onto that big chair as long as he can.
https://www.cytodyn.com/newsroom/press-releases/detail/535/biomm-s-a-announces-plans-to-submit-authorization-to
Well technically it was... they applied for the right to ask if they could possibly sell LL at some point in the future. For that they paid 400 coconuts. So clearly it’s a done deal! (in 2 weeks)
lol. We're all like flies to honey with this thing (or maybe it's more like flies to #### ?).I'm back in. Missed seeing it on my portfolio.
I bought 4 shares.
Hamster on a wheel. Lots of motion but isn't going anywhere.It's not even THAT good. It's a press release to announce they haven't yet, but are going to, sometime over the next few days, submit a request to Brazil to authorize CYDY to conduct two trials.
Lightning speed, folks.
So, 80% of the FFA?Hamster on a wheel. Lots of motion but isn't going anywhere.
Reminds me of the guy at work who puts up a good show that he's busy but isn't doing anything that matters.
Finished up .51% today.I'm back in. Missed seeing it on my portfolio.
I bought 4 shares.
AmazingIt's not even THAT good. It's a press release to announce they haven't yet, but are going to, sometime over the next few days, submit a request to Brazil to authorize CYDY to conduct two trials.
Lightning speed, folks.
Me toolol. We're all like flies to honey with this thing (or maybe it's more like flies to #### ?).
CYDY and the moves they make under NP make a lot more sense if you view them as intentional instead of incompetence.I swear, I'm gonna straight up cold-call these folks and harass them into hiring me for press releases.
Of course, I'd drop right in here and have you all contribute to, or outright produce them for company. Yeah, yeah, yeah I drink a lot. My drunk ### and the rest of you could do better than this bunch of muppets
Honestly NP should be CEO of the year/decade. He’s kept this garbage company relevant for years.CYDY and the moves they make under NP make a lot more sense if you view them as intentional instead of incompetence.
They know the drug is doo doo. They're just doing the best they can.
This is the hard part. I know chet...I mean hung out with him twice which is a lot for meeting someone from this site.Honestly NP should be CEO of the year/decade. He’s kept this garbage company relevant for years.
mini madoff.
I do not think that Chet is a scammer either but has good reasons for believing in the drug.This is the hard part. I know chet...I mean hung out with him twice which is a lot for meeting someone from this site.
Chet is not a scammer and believes what he does.
Chet never asked me to invest in this stock. If he did I would be retired. I got in at a dollar and he only reached out to me after I posted i bought 10k shares or something like that.
Once I put in 100k, yeah we talked.
I agree but even with a poorly designed study, if the drug was great it should have done well.I do not think that Chet is a scammer either but has good reasons for believing in the drug.
The mgt is another story.
Dosage is important though and if they severely messed that up, which by all accounts they did, then that is a valid reason why it wouldn't be as effective.I agree but even with a poorly designed study, if the drug was great it should have done well.
Agree doesn't look like it works for covid. The rantes/pantes stuff etc and Patterson doesn't have traction in scientific community.I agree but even with a poorly designed study, if the drug was great it should have done well.
The other thing though is that it is hard to trust anything the company offers/presents choose whatever word you want. I also think the company is at risk from the stockholder suit and the potential for SEC involvement.Dosage is important though and if they severely messed that up, which by all accounts they did, then that is a valid reason why it wouldn't be as effective.
Jury is still out for sure.
Its a long time to wait for their next chance to prove themselves. That's the biggest issue right now that I see. I honestly hope Covid for all intents and purposes is really diminished by the time this Brazil trial is done.
All that being said, I'm planning to put some money down if I get the right price. Still want in that $1.50 to $1.60 range
I don't think Chet is a scammer, but Chet wouldn't be the only one fooled by NP.This is the hard part. I know chet...I mean hung out with him twice which is a lot for meeting someone from this site.
Chet is not a scammer and believes what he does.
Chet never asked me to invest in this stock. If he did I would be retired. I got in at a dollar and he only reached out to me after I posted i bought 10k shares or something like that.
Once I put in 100k, yeah we talked.
If it were just NP, nobody would be thinking about buying this stock.I don't think Chet is a scammer, but Chet wouldn't be the only one fooled by NP.
We know NP is a liar. He's a damn good one too.
You mean Patterson - who's company will benefit from LL? Or all the MDs who are part of CYDY or used to be?If it were just NP, nobody would be thinking about buying this stock.
You still have good Doctors that are endorsing it.
And the HIV primary endpoint hit, and the people that have been on it for years? All lies?You mean Patterson - who's company will benefit from LL? Or all the MDs who are part of CYDY or used to be?
The only ones without a stake in CYDY are a Twitter MD and Dr. Yang. Yang ran a clinical trial and while he's supportive of LL, he's not exactly screaming pantes.
NP has done a masterful job at getting CYDY to where it was.
Try keeping up please. Chet has railed on NP relentlessly for about a year now.I don't think Chet is a scammer, but Chet wouldn't be the only one fooled by NP.
We know NP is a liar. He's a damn good one too.
No, but no BLA yet.And the HIV primary endpoint hit, and the people that have been on it for years? All lies?
Touche.Try keeping up please. Chet has railed on NP relentlessly for about a year now.
Chet in no way got into this stock because of NP. From his first post to now, it about the drug. And his first post said it was extremely risky.
Sold for a 9% profit in less than a week. Booyah.I'm back in. Missed seeing it on my portfolio.
I bought 4 shares.
Signs of success in the Philippines.One of the patient successes was recently reported last week on One News Philippines TV station. This patient had severe COVID-19 with deteriorating lung function despite treatment with antivirals and steroids. Testing was significant for high inflammation in the blood with Ferritin 17x elevated. Oxygen saturation on maximum oxygen flow was only 82% (normal >95%). Twenty hours after receiving 700 mg of leronlimab subcutaneously at the patient's home, the patient's heart rate decreased from 120s to low 90s. Shortly thereafter the patient regained appetite, improved lung function, and had reduced inflammation with Ferritin down to 4x elevated. At week two, the patient successfully went off oxygen shortly after second dose also given at home. At week three, the patient continued to improve in stamina and returned to routine physical activities. Inflammation markers were still elevated with Ferritin still two times elevated, so a third dose was given. At week four, the patient is currently back to normal life activities."